Spyre Therapeutics, Inc. (SYRE)
96.56
-2.40
(-2.43%)
USD |
NASDAQ |
Oct 30, 16:00
96.51
-0.05
(-0.05%)
Pre-Market: 20:00
Spyre Therapeutics 30-Day Average Daily Volume : 1.312M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.312M |
| October 29, 2026 | 1.402M |
| October 28, 2026 | 1.431M |
| October 27, 2026 | 1.449M |
| October 26, 2026 | 1.446M |
| October 23, 2026 | 1.461M |
| October 22, 2026 | 1.474M |
| October 21, 2026 | 1.478M |
| October 20, 2026 | 1.473M |
| October 19, 2026 | 1.457M |
| October 16, 2026 | 1.442M |
| October 15, 2026 | 1.434M |
| October 14, 2026 | 1.442M |
| October 13, 2026 | 1.435M |
| October 12, 2026 | 1.451M |
| October 09, 2026 | 1.464M |
| October 08, 2026 | 1.466M |
| October 07, 2026 | 1.492M |
| October 06, 2026 | 1.432M |
| October 05, 2026 | 1.312M |
| October 02, 2026 | 1.324M |
| October 01, 2026 | 1.306M |
| September 30, 2026 | 1.290M |
| September 29, 2026 | 1.251M |
| September 28, 2026 | 1.246M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.230M |
| September 24, 2026 | 1.229M |
| September 23, 2026 | 1.201M |
| September 22, 2026 | 1.202M |
| September 21, 2026 | 1.188M |
| September 18, 2026 | 1.158M |
| September 17, 2026 | 1.061M |
| September 16, 2026 | 1.048M |
| September 15, 2026 | 1.033M |
| September 14, 2026 | 1.035M |
| September 11, 2026 | 1.019M |
| September 10, 2026 | 1.018M |
| September 09, 2026 | 1.028M |
| September 08, 2026 | 1.045M |
| September 04, 2026 | 1.026M |
| September 03, 2026 | 1.026M |
| September 02, 2026 | 1.012M |
| September 01, 2026 | 986380.4 |
| August 31, 2026 | 964628.1 |
| August 28, 2026 | 925862.4 |
| August 27, 2026 | 920026.5 |
| August 26, 2026 | 926865.5 |
| August 25, 2026 | 873711.7 |
| August 24, 2026 | 935470.6 |
| August 21, 2026 | 948746.5 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.796M |
| Incyte Corp. | 1.814M |
| SELLAS Life Sciences Group, Inc. | 6.172M |
| Relay Therapeutics, Inc. | 2.685M |
| ACADIA Pharmaceuticals, Inc. | 2.037M |